Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Mauna Kea Reports Decline in FY15 Sales

Facebook Twitter LinkedIn Email Comments
Global medical device company Mauna Kea Technologies ended its 2015 fiscal year with a 22 percent decline from its 2014 sales.

"Following our announcement on October 8 of the company's intent to modify its commercialization strategy, we anticipated a dilution of sales productivity as the global leadership team and regional sales leaders worked to implement our new strategy,” said Sacha Loiseau, founder and CEO of Mauna Kea.

Sales in the Americas declined by 10 percent, with Mauna Kea citing the absence of sales in Brazil and its sluggish economy, compounded by a general slowdown of public funding. North American sales rose by 14 percent, while Asian-Pacific sales declined by 35 percent as a result of the delay in obtaining regulatory approval for the Cellvizio 100 microscopy system in China. Sales in Europe, the Middle East and Africa dropped 23 percent.

Mauna Kea Technologies is a global medical device company focused on endomicroscopy and tissue characterization.

Apr 2016
BusinessEuropeFranceMauna KeaBiophotonicsendoscopyCellvizioearningsRapidScan

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2021 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.